<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ANG</journal-id>
<journal-id journal-id-type="hwp">spang</journal-id>
<journal-id journal-id-type="nlm-ta">Angiology</journal-id>
<journal-title>Angiology</journal-title>
<issn pub-type="ppub">0003-3197</issn>
<issn pub-type="epub">1940-1574</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0003319711425921</article-id>
<article-id pub-id-type="publisher-id">10.1177_0003319711425921</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dental Management of Antiplatelet-Receiving Patients: Is Uninterrupted Antiplatelet Therapy Safe?</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Koskinas</surname>
<given-names>Konstantinos C.</given-names>
</name>
<degrees>MD, MSc, FESC</degrees>
<xref ref-type="aff" rid="aff1-0003319711425921">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lillis</surname>
<given-names>Theodoros</given-names>
</name>
<degrees>DDS, MSc</degrees>
<xref ref-type="aff" rid="aff2-0003319711425921">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsirlis</surname>
<given-names>Anastasios</given-names>
</name>
<degrees>DDS, PhD</degrees>
<xref ref-type="aff" rid="aff2-0003319711425921">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katsiki</surname>
<given-names>Niki</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0003319711425921">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giannoglou</surname>
<given-names>George D.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711425921">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ziakas</surname>
<given-names>Antonios G.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0003319711425921">1</xref>
<xref ref-type="corresp" rid="corresp1-0003319711425921"/>
</contrib>
</contrib-group>
<aff id="aff1-0003319711425921"><label>1</label>1st Cardiology Department, AHEPA University Hospital, Aristotle University Medical School, Thessaloniki, Greece</aff>
<aff id="aff2-0003319711425921"><label>2</label>Department of Dentoalveolar Surgery, Implant Surgery and Radiology, Aristotle University Dental School, Thessaloniki, Greece</aff>
<aff id="aff3-0003319711425921"><label>3</label>First Department of Internal Medicine, Agios Dimitrios General Hospital, Thessaloniki, Greece</aff>
<author-notes>
<corresp id="corresp1-0003319711425921">Antonios G. Ziakas, 1st Cardiology Department, AHEPA University Hospital, Aristotle University Medical School, 1 St Kyriakidi Street, 54636 Thessaloniki, Greece Email: <email>tonyziakas@hotmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>63</volume>
<issue>4</issue>
<fpage>245</fpage>
<lpage>247</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>The population of patients eligible for chronic antiplatelet treatment is expanding globally, in tandem with the rising prevalence of cardiovascular disease and the increasing use of percutaneous coronary interventions. While antiplatelet agents have revolutionized the management of atherosclerotic disease and its thrombotic complications,<sup>
<xref ref-type="bibr" rid="bibr1-0003319711425921">1</xref>
</sup> the potential of bleeding remains an inherent risk. Temporary withdrawal of antiplatelet therapy may therefore seem an attractive option in iatrogenic settings that pose a bleeding hazard; in this case, however, the benefit of averting antiplatelet-induced hemorrhage needs to be balanced against the risk of potentially fatal thrombosis, particularly in the expanding cohort of patients with drug-eluting stents (DES).<sup>
<xref ref-type="bibr" rid="bibr2-0003319711425921">2</xref>,<xref ref-type="bibr" rid="bibr3-0003319711425921">3</xref>
</sup>
</p>
<p>Dental extractions represent the most frequent minor surgical procedures in the general population, yet the optimal dental management of antiplatelet-receiving patients is insufficiently explored. Sporadic cases of postextraction bleeding have been reported in the setting of continuous aspirin therapy, but reports of serious or life-threatening hemorrhage are extremely rare.<sup>
<xref ref-type="bibr" rid="bibr4-0003319711425921">4</xref><xref ref-type="bibr" rid="bibr5-0003319711425921"/><xref ref-type="bibr" rid="bibr6-0003319711425921"/><xref ref-type="bibr" rid="bibr7-0003319711425921"/>–<xref ref-type="bibr" rid="bibr8-0003319711425921">8</xref>
</sup> Very few studies have systematically assessed the effect of aspirin or clopidogrel on the procedural outcome of dental treatment<sup>
<xref ref-type="bibr" rid="bibr9-0003319711425921">9</xref><xref ref-type="bibr" rid="bibr10-0003319711425921"/><xref ref-type="bibr" rid="bibr11-0003319711425921"/><xref ref-type="bibr" rid="bibr12-0003319711425921"/><xref ref-type="bibr" rid="bibr13-0003319711425921"/>–<xref ref-type="bibr" rid="bibr14-0003319711425921">14</xref>
</sup>; these studies generally focused on the safety of dental procedures in the setting of uninterrupted antiplatelet monotherapy. The safety of dual antiplatelet therapy has been studied to an even lesser extent, and even these studies were limited by their retrospective design and by the small and heterogeneous patient populations.<sup>
<xref ref-type="bibr" rid="bibr15-0003319711425921">15</xref>,<xref ref-type="bibr" rid="bibr16-0003319711425921">16</xref>
</sup> In the most comprehensive relevant report, Napeñas et al included 29 patients receiving dual antiplatelet treatment and found a very low frequency of prolonged postextraction bleeding; however, the heterogeneity of the invasive procedures and the absence of a group of antiplatelet-naive controls limited the interpretation of their results.<sup>
<xref ref-type="bibr" rid="bibr15-0003319711425921">15</xref>
</sup>
</p>
<p>In light of the paucity of relevant studies, and particularly the absence of prospective investigations, defining a strategy to optimally balance the bleeding risk of uninterrupted antiplatelet therapy versus the thrombotic hazard of temporary antiplatelet withdrawal before dental procedures has been an unanswered question for a frequent clinical problem. Current recommendations suggest uninterrupted antiplatelet therapy in patients with DES undergoing dental procedures.<sup>
<xref ref-type="bibr" rid="bibr17-0003319711425921">17</xref>
</sup> In striking contrast to these recommendations, however, antiplatelet agents are frequently interrupted in everyday practice. This is clearly an empirical, rather than an evidence-based approach, based on excessive concerns about potential postextraction bleeding complications.</p>
<p>Aiming to address this gap of evidence-based practice, the safety of dental extractions during uninterrupted single or dual antiplatelet treatment was recently assessed in a prospective fashion. In a study published in the <italic>American Journal of Cardiology</italic>,<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> we included 643 patients referred for dental extractions. Of them, 42 (6.5%) were on clinically indicated daily low-dose aspirin, 36 (5.6%) were on clopidogrel, 33 (5.1%) were on both aspirin and clopidogrel, while 532 antiplatelet-naive patients served as controls.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> Treatment groups and controls were well matched clinically and received similar procedural treatment, thereby allowing for direct comparison of the relative risk attributable to each antiplatelet regimen. Immediate bleeding events, defined as those occurring during the extraction session, were more frequent in patients on dual therapy compared with those on monotherapy or controls.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> Of clinical importance, however, all bleeding events occurred early, within the safe environment of the dental clinic, and could all be controlled by local hemostatic measures that are widely available to all dental practitioners. No significant late bleeding, that is, occurring at any time after patient discharge, was reported.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> Overall, and notwithstanding certain limitations such as the nonrandomized study design and the relatively small sample size, this study adds to the conjecture that dental extractions may be safely performed in patients receiving antiplatelet agents when appropriate local hemostatic measures are taken.</p>
<p>Extrapolation of these findings to everyday practice must be done with caution. While not statistically significant (likely due to the small number of patients), bleeding incidence was substantially (6-fold) higher in the antiplatelet monotherapy groups compared with controls.<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> Not surprisingly, the relative risk of immediate bleeding was more than 100-fold increased in patients on dual therapy. Taken together, if procedural safety were to be based merely on the frequency of local hemorrhage, then our study might be interpreted as evidence of higher bleeding risk in antiplatelet-treated patients, particularly for the combination of aspirin + clopidogrel. However, if other, clinically meaningful parameters are taken into account in assessing the overall procedural safety, such as the time frame of occurrence and the efficient control of bleeding events, then the balance of risk in our study clearly weighs in favor of continuing antiplatelet therapy, thereby averting the thrombotic risk of temporary antiplatelet discontinuation.</p>
<p>While our study adds substantially to previous evidence, many questions still remain answer and deserve further investigation. We only included patients with up to 3 extractions at a session; therefore, our results cannot be generalized to more complex cases with multiple extractions. The safety of antiplatelet agents other than aspirin and clopidogrel, for example, prasugrel, ticagrelor, or ticlopidine, was not assessed. Methodologically, our study was not designed to directly compare hemorrhagic risk, and more importantly, the potential thrombotic complications between continuous versus interrupted antiplatelet treatment; such a direct comparison might be a goal to pursue in future work. In a wider perspective, it is not clear from our study whether switching temporarily from double to single antiplatelet therapy prior to the extraction might further enhance procedural safety, while at the same time retaining the antithrombotic protection that is particularly critical for patients with DES. Similarly, postponing nonurgent dental procedures until patients move from dual antiplatelet therapy to monotherapy, as clinically indicated, might be a reasonable alternative. However, in this case, the presumed gain in procedural safety would need to be balanced against the adverse impact on quality of life resulting from untreated dental problems.</p>
<p>Optimal dental management of patients on antiplatelet treatment remains a frequent, challenging issue faced by dentists and cardiologists. Recent evidence supports the procedural safety of performing dental procedures without interrupting antiplatelet agents,<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> yet certain prerequisites would be critical to enhance the benefit-to-risk ratio of this approach. Because of the substantial interindividual variability in response to drug effect<sup>
<xref ref-type="bibr" rid="bibr19-0003319711425921">19</xref>
</sup> and in intrinsic bleeding tendency, dentists should be particularly cautious to inquire about comorbidities or concomitant medications that augment bleeding diathesis. In higher-risk, bleeding-prone patients, procedures may need to be performed in clinics with a hemostasis unit backup. Procedure-wise, placement of local hemostatic agents and suturing<sup>
<xref ref-type="bibr" rid="bibr18-0003319711425921">18</xref>
</sup> rather than the routine postextraction treatment of only applying a pressure pack may accelerate local hemostasis and reduce the likelihood of delayed bleeding. In addition, close postprocedure follow-up, requiring adequate patient contact information, would be essential to ensure that potential delayed bleeding events are treated appropriately.</p>
<p>Overall, decision making concerning dental management of antiplatelet-receiving patients will need to be individualized and risk-tailored, choosing between the Scylla of local bleeding and the Charybdis of thrombosis in high-risk patients.</p>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-0003319711425921">
<p>The authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0003319711425921">
<p>The authors received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0003319711425921">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>SC</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Allen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>SN</given-names>
</name>
<etal/>
</person-group>. <article-title>AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute</article-title>. <source>J Am Coll Cardiol</source>. <year>2006</year>;<volume>47</volume>(<issue>10</issue>):<fpage>2130</fpage>–<lpage>2139</lpage>.</citation>
</ref>
<ref id="bibr2-0003319711425921">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iakovou</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bonizzoni</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>293</volume>(<issue>17</issue>):<fpage>2126</fpage>–<lpage>2130</lpage>.</citation>
</ref>
<ref id="bibr3-0003319711425921">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Serruys</surname>
<given-names>PW</given-names>
</name>
</person-group>. <article-title>Coronary stents. Current status</article-title>. <source>J Am Coll Cardiol</source>. <year>2010</year>;<volume>56</volume>(<issue>10 suppl</issue>):<fpage>S1</fpage>–<lpage>S42</lpage>.</citation>
</ref>
<ref id="bibr4-0003319711425921">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lemkin</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Billesdon</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Davee</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Leake</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Kattlove</surname>
<given-names>HE</given-names>
</name>
</person-group>. <article-title>Aspirin-induced oral bleeding: correction with platelet transfusion. A reminder</article-title>. <source>Oral Surg Oral Med Oral Pathol</source>. <year>1974</year>;<volume>37</volume>(<issue>4</issue>):<fpage>498</fpage>–<lpage>501</lpage>.</citation>
</ref>
<ref id="bibr5-0003319711425921">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foulke</surname>
<given-names>CN</given-names>
</name>
</person-group>. <article-title>Gingival hemorrhage related to aspirin ingestion. A case report</article-title>. <source>J Periodontol</source>. <year>1976</year>;<volume>47</volume>(<issue>6</issue>):<fpage>355</fpage>–<lpage>357</lpage>.</citation>
</ref>
<ref id="bibr6-0003319711425921">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGaul</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Postoperative bleeding caused by aspirin</article-title>. <source>J Dent</source>. <year>1978</year>;<volume>6</volume>(<issue>3</issue>):<fpage>207</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr7-0003319711425921">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomason</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Seymour</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brigham</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Aspirin-induced post-gingivectomy haemorrhage: a timely reminder</article-title>. <source>J Clin Periodontol</source>. <year>1997</year>;<volume>24</volume>(<issue>2</issue>):<fpage>136</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr8-0003319711425921">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chackartchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Shapira</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Findler</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>A critically severe gingival bleeding following non-surgical periodontal treatment in patients medicated with anti-platelet</article-title>. <source>J Clin Periodontol</source>. <year>2008</year>;<volume>35</volume>(<issue>4</issue>):<fpage>342</fpage>–<lpage>345</lpage>.</citation>
</ref>
<ref id="bibr9-0003319711425921">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ardekian</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gaspar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peled</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brener</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Laufer</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>Does low-dose aspirin therapy complicate oral surgical procedures?</article-title> <source>J Am Dent Assoc</source>. <year>2000</year>;<volume>131</volume>(<issue>3</issue>):<fpage>331</fpage>–<lpage>335</lpage>.</citation>
</ref>
<ref id="bibr10-0003319711425921">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madan</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Madan</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Madan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Madan</surname>
<given-names>AD</given-names>
</name>
</person-group>. <article-title>Minor oral surgery without stopping daily low-dose aspirin therapy: a study of 51 patients</article-title>. <source>J Oral Maxillofac Surg</source>. <year>2005</year>;<volume>63</volume>(<issue>9</issue>):<fpage>1262</fpage>–<lpage>1265</lpage>.</citation>
</ref>
<ref id="bibr11-0003319711425921">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shenoy</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Exodontia and antiplatelet therapy</article-title>. <source>J Oral Maxillofac Surg</source>. <year>2008</year>;<volume>66</volume>(<issue>10</issue>):<fpage>2063</fpage>–<lpage>2066</lpage>.</citation>
</ref>
<ref id="bibr12-0003319711425921">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardona-Tortajada</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Sainz-Gómez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Figuerido-Garmendia</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Dental extractions in patients on antiplatelet therapy. A study conducted by the Oral Health Department of the Navarre Health Service (Spain)</article-title>. <source>Med Oral Patol Oral Cir Bucal</source>. <year>2009</year>;<volume>14</volume>(<issue>11</issue>):<fpage>e588</fpage>–<lpage>e592</lpage>.</citation>
</ref>
<ref id="bibr13-0003319711425921">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garnier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Truchot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Quero</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>218 tooth extraction in patients taking platelet aggregation inhibitors</article-title>. <source>Rev Stomatol Chir Maxillofac</source>. <year>2007</year>;<volume>108</volume>(<issue>5</issue>):<fpage>407</fpage>–<lpage>410</lpage>.</citation>
</ref>
<ref id="bibr14-0003319711425921">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brennan</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Valerin</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Noll</surname>
<given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Aspirin use and post-operative bleeding from dental extractions</article-title>. <source>J Dent Res</source>. <year>2008</year>;<volume>87</volume>(<issue>8</issue>):<fpage>740</fpage>–<lpage>744</lpage>.</citation>
</ref>
<ref id="bibr15-0003319711425921">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napeñas</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Furney</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Lockhart</surname>
<given-names>PB</given-names>
</name>
</person-group>. <article-title>The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy</article-title>. <source>J Am Dent Assoc</source>. <year>2009</year>;<volume>140</volume>(<issue>6</issue>):<fpage>690</fpage>–<lpage>695</lpage>.</citation>
</ref>
<ref id="bibr16-0003319711425921">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cañigral</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Silvestre</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Cañigral</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Alós</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia-Herraiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Plaza</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Evaluation of bleeding risk and measurement methods in dental patients</article-title>. <source>Med Oral Patol Oral Cir Bucal</source>. <year>2010</year>;<volume>15</volume>(<issue>6</issue>):<fpage>e863</fpage>–<lpage>e868</lpage>.</citation>
</ref>
<ref id="bibr17-0003319711425921">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grines</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Bonow</surname>
<given-names>RO</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>DE</given-names>
<suffix>Jr</suffix>
</name>
<etal/>
</person-group>. <article-title>Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of Physicians</article-title>. <source>Circulation</source>. <year>2007</year>;<volume>115</volume>(<issue>6</issue>):<fpage>813</fpage>–<lpage>818</lpage>.</citation>
</ref>
<ref id="bibr18-0003319711425921">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lillis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ziakas</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koskinas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsirlis</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giannoglou</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Safety of dental extractions during uninterrupted single or dual antiplatelet treatment</article-title>. <source>Am J Cardiol</source>. <year>2011</year>;<volume>108</volume>:<fpage>964</fpage>–<lpage>967</lpage>.</citation>
</ref>
<ref id="bibr19-0003319711425921">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angiolillo</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Fernandez-Ortiz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bernardo</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives</article-title>. <source>J Am Coll Cardiol</source>. <year>2007</year>;<volume>49</volume>(<issue>14</issue>):<fpage>1505</fpage>–<lpage>1516</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>